674PD - Perioperative FLOT + anti-PD-L1 avelumab (FLOT-A) chemo-immunotherapy in resectable oesophagogastric adenocarcinoma (OGA): Safety and biomarker data from the ICONIC trial safety run-in
| Autor: | Davidson, M., Mansukhani, S., Starling, N., Chau, I., Watkins, D., Cunningham, D., Rao, S., Lazaro-Alcausi, R., Griffiths, B., Barber, L., Morganstein, D., Forster, M.D., Davies, S., Begum, R., Gillbanks, A., Kalaitzaki, E., Wotherspoon, A., Von Loga, K., Chaudry, A., Gerlinger, M. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v254-v254 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|